Brazil approves Sinovac COVID-19 vaccine for youth aged 6-17
CGTN, 22 Jan 2022
For more:
https://news.cgtn.com/news/2022-01-22/Brazil-approves-Sinovac-COVID-19-vaccine-for-youth-aged-6-17-171EKF63Ymk/index.html
#Brazil, on Thursday, approved the use of Chinese biopharmaceutical company #Sinovac's #COVID-19 vaccine for non-immunocompromised young people aged 6 to 17. The Brazilian Health Regulatory Agency, Anvisa, said it would evaluate the use of the Sinovac vaccine on children aged three to five once it obtained more data.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://news.cgtn.com/news/2022-01-22/Brazil-approves-Sinovac-COVID-19-vaccine-for-youth-aged-6-17-171EKF63Ymk/index.html
#Brazil, on Thursday, approved the use of Chinese biopharmaceutical company #Sinovac's #COVID-19 vaccine for non-immunocompromised young people aged 6 to 17. The Brazilian Health Regulatory Agency, Anvisa, said it would evaluate the use of the Sinovac vaccine on children aged three to five once it obtained more data.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
